Author Archives: Lu Rahman

#Drug discovery #Drug targets

Webinar: Hit discovery for trained immunity and tolerance

Do you want to learn about: Trained immunity The role of epigenetic targets in trained immunity Hit discovery through ultra-high throughput screening of large libraries Industry standard Hit-to-Lead biological profiling frameworks Join Dr. Saman Honarnejad, Director Drug Discovery at Pivot Park Screening Centre​ on 14 December 3PM (GMT) for this… Read More

#News

#Biobanking #NGS #Protein chemistry / Proteomics

Olink’s protein biomarker technology to provide data from 53,000 participants

The Olink Proteomics Olink Explore 1536 platform, using Next Generation Sequencing (NGS) as read-out, will be used in a project to measure plasma protein concentration in 53,000 individuals from the UK Biobank, one of the world’s largest genetic resources. The project is funded by a consortium of ten biopharmaceutical companies. Read More

#Editor's Choice #News

#Biologics / Biotechnology #Covid-19 #Immunology / Virology & Vaccines #Pharmaceutical

Seppic boosts presence in the human vaccine adjuvant market

Seppic’s Sepivac SWETM vaccine adjuvant for human use can contribute to the development of vaccine solutions to fight seasonal and pandemic influenza, as well as COVID-19. Together with various international partners, Seppic is participating in the global research effort to develop a vaccine solution against COVID-19. These programs are in… Read More

#Covid-19 #News

#Biologics / Biotechnology #Biomanufacturing #Cell therapy #Drug development

Cedars-Sinai biomanufacturing centre spurs cell therapies to help develop new drugs

Cedars-Sinai has launched a centre to manufacture the next generation of stem cell and gene therapies that will enable biomedical researchers, government medical programs, commercial entities and others to develop new biologic drugs and propel novel disease discoveries. Biologic drugs are produced from living organisms or contain components of living… Read More

#Editor's Choice #News

#AI / data analytics / healthtech / informatics #Biologics #Drug development

IDBS Polar launch streamlines biopharmaceutical development

IDBS has launched Polar biopharma lifecycle management (BPLM),  which is aimed at streamlining drug development and manufacturing in biopharma research. The development of biologics is a dynamic process and those who are most successful must be able to adapt to changes in process or technology rapidly. IDBS data has found… Read More

#News

#Cellular & Molecular biology #Oncology

Scientists use geometry to track cell migrations with potential impact for cancer research

https://www.ddw-online.com/wp-content/uploads/2020/12/collage.mp4   Cells are constantly moving throughout our bodies, performing functions crucial to tissue development, immune responses and general wellbeing. This locomotion—an essential feature of biological processes, both normal and pathological—is guided by chemical cues long studied by scientists interested in cellular migration. But a team of physicists and… Read More

#Cancer Research #Editor's Choice #News #Videos

#Covid-19 #Immunology / Virology & Vaccines

Moderna vaccine: helps antibodies last for three months

In a letter published in the New England Journal of Medicine, Moderna has reported that participants in the Phase I study its mRNA-1273 COVID-19 vaccine candidate, retained high levels of neutralising antibodies for 119 days following first vaccination (90 days following second vaccination). The study was led by the National Institute… Read More

#Covid-19 #News #Trending News

#AI / data analytics / healthtech / informatics #Therapeutics

Sitting down with…Orexo, digital therapeutic expert

Orexo recently launched the digital therapies deprexis and vorvida in the US. Lu Rahman talked to Nikolaj Sørensen, President and CEO about these therapies and the company’s expertise LR: Explain how digital therapies work and the type of conditions they are most suited to treat. NS: Digital therapeutics are evidence-based… Read More

#Editor's Choice #Exclusive Content #News #Opinion

#AI / data analytics / healthtech / informatics #Cell culture #Drug development

Ground-breaking techniques using AI predict cell growth

Ground-breaking research at Teesside University using artificial intelligence to predict the growth rate of living organisms could have far-reaching consequences in the field of pharmaceuticals and medical diagnostics. A team of researchers led by Dr Claudio Angione from the University’s School of Computing, Engineering and Digital Technology looked at how… Read More

#News

#AI / data analytics / healthtech / informatics #Drug discovery

Project produces next-generation AI drug discovery platform

The consortium behind the DeepADMET project set up to advance artificial intelligence (AI) technologies for drug discovery, has announced the successful conclusion of this project which was funded by Innovate UK, the UK’s innovation agency. Optibrium – a developer of software for drug discovery, Intellegens – an AI company, and… Read More

#News

#Biotechnology #Cell therapy #Covid-19 #Gene therapy #Immunology / Virology & Vaccines #Pharmaceutical

Investment banking head offers market outlook for 2021

The Jefferies Healthcare Temperature Check report is now in its third edition and published to coincide with the 11th annual Global Healthcare Conference which was held virtually. Over 500 responses from senior leaders in the sector responded for this year’s report, giving views on both the current state of the… Read More

#Business & Investment #Editor's Choice #Exclusive Content #Market Reports #News #Opinion #Trends & Analysis

#Covid-19 #Therapeutics

How SARS-CoV-2 hijacks and damages lung cells offers insight for therapeutic targets

In a collaboration  involving the National Emerging Infectious Disease Laboratories (NEIDL), the Center for Regenerative Medicine (CReM), and the Center for Network Systems Biology (CNSB), scientists have reported the first map of the molecular responses of human lung cells to infection by SARS-CoV-2. By combining bioengineered human alveolar cells with… Read More

#Covid-19 #News

#Antibodies #Biotechnology

Sterling announces strategic investment in ADC Biotechnology

Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions (Sterling), has announced a new strategic partnership with ADC Biotechnology (ADC Bio), a UK based biotechnology company specialising in antibody drug conjugates. The partnership will see Sterling make a significant investment in the business with a view to acquiring ADC… Read More

#News

#Covid-19 #Immunology / Virology & Vaccines

Pfizer vaccine approval: biotech innovation brings positivity for UK private sector

This week has provided hope and optimism that the end of the pandemic is finally in sight, with the UK becoming the first country in the world to approve the Pfizer/BioNTech coronavirus vaccine for widespread use. With almost half of Britain now in Tier 3 and many small businesses facing… Read More

#Business & Investment #Covid-19 #Editor's Choice #Exclusive Content #News #Trending News

#AI / data analytics / healthtech / informatics #Covid-19

Watch now: COVID Moonshot – Data Coordination Strategy

The COVID Moonshot is a global consortium that aims to rapidly develop antivirals for COVID-19. Dr. Lizbe Koekemoer of Oxford University describes how the project team leverages the CDD Vault informatics platform to effectively store, manage, and share data among multiple international partners.    … Read More

#Covid-19 #Videos

#Covid-19 #Immunology / Virology & Vaccines #Marketing approval authorisation

Pfizer / BioNTech vaccine approved and available for use in the UK next week

The Pfizer/BioNTech COVID-19 vaccine has been authorised for emergency use by the Medicines and Healthcare Products Regulatory Authority (MHRA). Pfizer and BioNTech recently announced final efficacy analysis in their Phase III study for their mRNA-based COVID-19 vaccine candidate BNT162b2, which showed an efficacy rate of 95% in participants without prior… Read More

#Covid-19 #News #Trending News